Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline NXST Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance TBN Q1 2026 Earnings WiderThanExpected Loss Sends Stock Lower ASST Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid PreRevenue Phase My Size Inc MYSZ Q4 2025 Earnings EPS Falls Short of Expectations Amid Revenue Disclosures ATKR Q1 2026 Earnings Strong EPS Surprise Lifts Shares by 1125